凯莱拉治疗

最新新闻

• 评级变动
  TD Cowen Maintains Kailera Therapeutics(KLRA.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/5/27
• 评级变动
  A Quick Look at Today's Ratings for Kailera Therapeutics(KLRA.US), With a Forecast Between $30 to $48
  \u5e02\u573a\u8d44\u8baf · 2026/5/12
• TD Cowen Sticks to Its Buy Rating for Kailera Therapeutics, Inc. (KLRA)
  TipRanks · 2026/9/30
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Medicus Pharma Ltd (MDCX) and Kailera Therapeutics, Inc. (KLRA)
  TipRanks · 2026/8/14
• 评级变动
  J.P. Morgan Maintains Kailera Therapeutics(KLRA.US) With Buy Rating, Maintains Target Price $30
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• TD Cowen Maintains Kailera Therapeutics(KLRA.US) With Buy Rating, Maintains Target Price $57
  \u5e02\u573a\u8d44\u8baf · 2026/9/30
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Kailera Therapeutics, Inc. (KLRA), Warby Parker (WRBY) and Aprea Therapeutics (APRE)
  TipRanks · 2026/8/13
• 评级变动
  Jefferies Keeps Their Buy Rating on Kailera Therapeutics, Inc. (KLRA)
  TipRanks · 2026/7/8
• 评级变动
  Analysts Offer Insights on NA Companies: Arxis, Inc. Class A (ARXS) and Kailera Therapeutics, Inc. (KLRA)
  TipRanks · 2026/5/18
• 评级变动
  Kailera Therapeutics, Inc. (KLRA) Receives a Buy From TD Cowen
  TipRanks · 2026/5/22
• 评级变动
  Analysts Offer Insights on NA Companies: Douglas AG (OtherDOUDF) and Kailera Therapeutics, Inc. (KLRA)
  TipRanks · 2026/5/12
• 评级变动
  TD Cowen Maintains Kailera Therapeutics(KLRA.US) With Buy Rating, Announces Target Price $57
  \u5e02\u573a\u8d44\u8baf · 2026/7/8
• William Blair Maintains Kailera Therapeutics(KLRA.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/30
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Acadia Healthcare (ACHC) and Kailera Therapeutics, Inc. (KLRA)
  TipRanks · 2026/7/8
• Jefferies Maintains Kailera Therapeutics(KLRA.US) With Buy Rating, Maintains Target Price $48
  \u5e02\u573a\u8d44\u8baf · 2026/8/14
• 评级变动
  Analysts' Opinions Are Mixed on These Healthcare Stocks: P3 Health Partners (PIII) and Kailera Therapeutics, Inc. (KLRA)
  TipRanks · 2026/8/13
• Analysts Offer Insights on Healthcare Companies: Kailera Therapeutics, Inc. (KLRA) and Immunome (IMNM)
  TipRanks · 2026/9/30
• 评级变动
  Evercore Initiates Kailera Therapeutics(KLRA.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/5/13
• 评级变动
  TD Cowen Initiates Kailera Therapeutics(KLRA.US) With Buy Rating, Announces Target Price $57
  \u5e02\u573a\u8d44\u8baf · 2026/5/13

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。